Why does lymphoma occur? causes and contributing factors

What causes Lymphoma?

Lymphoma is a type of cancer that originates in the lymphatic system, the network of tissues, vessels, and organs that play a vital role in the body’s immune defense. It develops when lymphocytes, a type of white blood cell, begin to grow and multiply uncontrollably, forming tumors in lymph nodes, the spleen, the thymus, bone marrow, and other parts of the body. Lymphoma is broadly divided into two main categories: Hodgkin lymphoma (HL) and Non-Hodgkin lymphoma (NHL), each with distinct characteristics, behaviors, and causes.

Understanding the causes of lymphoma is critical not only for developing better treatments but also for identifying risk factors and enabling earlier diagnosis. While no single definitive cause has been identified for most lymphomas, researchers have uncovered a complex interplay of genetic, environmental, infectious, and immunological factors that can significantly raise an individual’s risk of developing the disease.

1. Genetic factors and DNA mutations

At its most fundamental level, lymphoma, like all cancers, is a disease of DNA. The lymphocytes that become cancerous undergo mutations in their genetic material that disrupt normal cell regulation. These mutations can cause cells to grow without restraint, resist natural cell death (apoptosis),and invade surrounding tissues.

Certain chromosomal translocations are closely linked to lymphoma. In Burkitt lymphoma, a translocation involving the MYC gene on chromosome 8 is almost universally present. In follicular lymphoma, a translocation between chromosomes 14 and 18 activates the BCL2 gene, which prevents normal programmed cell death and allows malignant cells to survive indefinitely.

Family history also plays a role. Individuals with a first-degree relative who has had lymphoma are at a slightly elevated risk, suggesting that inherited genetic predispositions may contribute. However, lymphoma is not considered a strongly hereditary cancer, and most cases occur in people without a family history of the disease.

2. Viral and bacterial infections

Several infectious agents have been directly linked to the development of lymphoma, making infection one of the most well-established causes of certain lymphoma subtypes.

Epstein-Barr Virus (EBV)

The Epstein-Barr virus, best known for causing infectious mononucleosis (“mono”),is strongly associated with several lymphoma types, including Burkitt lymphoma, certain forms of Hodgkin lymphoma, and diffuse large B-cell lymphoma in immunocompromised individuals. EBV infects B lymphocytes and can drive them toward uncontrolled proliferation, especially when the immune system is unable to keep the infection in check.

Human Immunodeficiency Virus (HIV)

HIV infection substantially increases the risk of developing lymphoma, particularly Non-Hodgkin lymphomas such as diffuse large B-cell lymphoma and primary central nervous system lymphoma. HIV weakens the immune system, reducing its ability to suppress cancerous changes in lymphocytes and viral infections that trigger malignant transformation.

Human T-lymphotropic Virus (HTLV-1)

HTLV-1 is a retrovirus that infects T lymphocytes and is the direct cause of Adult T-cell leukemia/lymphoma (ATL),an aggressive malignancy particularly prevalent in parts of Japan, the Caribbean, and sub-Saharan Africa.

Helicobacter pylori (H. pylori)

This bacterium, known primarily for causing stomach ulcers, is also strongly linked to mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach. Chronic infection triggers persistent immune stimulation of lymphoid cells in the gastric lining, eventually driving malignant transformation. Remarkably, treating H. pylori with antibiotics can lead to complete remission in early-stage gastric MALT lymphoma.

3. Immune system dysfunction

The immune system is not only responsible for fighting infections; it also monitors and destroys abnormal cells, including those that might become cancerous. When the immune system is compromised or dysregulated, this protective function is lost, and lymphoma risk increases significantly.

Autoimmune diseases such as rheumatoid arthritis, lupus (systemic lupus erythematosus),and Sjögren’s syndrome have been associated with elevated lymphoma risk. In these conditions, the immune system is chronically overactivated, leading to persistent stimulation of lymphocytes and eventually increasing the probability of malignant mutations.

People who have received organ transplants and are taking immunosuppressive drugs to prevent rejection face a markedly elevated lymphoma risk. Post-transplant lymphoproliferative disorder (PTLD) is a well-recognized complication of immunosuppression, often driven by EBV in the context of a weakened immune response.

Congenital immunodeficiency syndromes, rare inherited conditions such as Wiskott-Aldrich syndrome, common variable immunodeficiency (CVID),and ataxia-telangiectasia, also substantially increase lymphoma risk, highlighting the crucial role of a healthy immune system in cancer prevention.

4. Environmental and chemical exposures

Exposure to certain environmental toxins and chemicals has been linked to an increased risk of lymphoma, although establishing direct causation is often complex due to the long latency periods involved.

Pesticides and herbicides have attracted significant scientific attention. Glyphosate, one of the world’s most widely used herbicides, has been classified as a “probable carcinogen” by the International Agency for Research on Cancer (IARC),with several epidemiological studies suggesting an association with Non-Hodgkin lymphoma. Agricultural workers with prolonged exposure to various pesticide classes appear to have elevated lymphoma rates.

Benzene, an industrial solvent found in gasoline and tobacco smoke, is a well-established carcinogen associated with blood-related malignancies, including lymphoma and leukemia. Occupational exposure in the petrochemical, rubber, and shoe-manufacturing industries has been particularly studied.

Ionizing radiation, from sources such as nuclear fallout, radiotherapy for prior cancers, or occupational exposure, can damage DNA in lymphocytes and increase lymphoma risk. Studies of survivors of the atomic bombings in Japan documented elevated rates of various lymphomas and leukemias in the decades following exposure.

5. Age and gender

Lymphoma can occur at any age, but risk patterns vary significantly between types. Hodgkin lymphoma has a bimodal age distribution, with peaks in young adults (ages 20–30) and in people over 55. Non-Hodgkin lymphoma, by contrast, becomes increasingly common with advancing age, with the majority of cases diagnosed in people over 60.

Gender also influences risk, as lymphoma is slightly more common in men than women for most subtypes, though the reasons for this difference are not fully understood. Hormonal, immune, and behavioral factors may all play a role.

6. Lifestyle factors

While lifestyle factors are less strongly linked to lymphoma than they are to some other cancers, certain behaviors may modulate risk. Obesity has been associated with an increased risk of some lymphoma subtypes, potentially through mechanisms involving chronic inflammation and immune dysregulation.

Smoking has been linked in some studies to elevated Hodgkin lymphoma and follicular lymphoma risk, although the data are less definitive than for many other cancers. Heavy alcohol consumption may similarly play a modest role. A diet low in fruits and vegetables and high in processed foods has been tentatively associated with increased NHL risk in some population studies.

7. Prior cancer treatment

Paradoxically, treatment for cancer can itself become a risk factor for subsequent lymphoma. Chemotherapy agents, particularly alkylating agents such as cyclophosphamide and chlorambucil, as well as radiation therapy, can damage the DNA of lymphocytes and other cells, potentially triggering secondary malignancies. This risk must always be weighed against the life-saving benefits of treating the primary cancer.

Conclusion

Lymphoma is a multifactorial disease with no single identifiable cause in the vast majority of cases. Instead, it arises from a convergence of genetic susceptibility, immune dysfunction, infectious triggers, environmental exposures, and lifestyle influences. Our understanding of its causes has advanced considerably over recent decades, leading to better-targeted therapies and more effective risk stratification.

For individuals at elevated risk, whether due to a compromised immune system, occupational exposures, viral infections, or family history, regular monitoring and early medical consultation remain the most effective tools for timely diagnosis. As research continues to unravel the molecular and environmental underpinnings of lymphoma, the prospect of true prevention, beyond managing known risk factors, draws ever closer.

If you have concerns about your own risk of lymphoma, consult a qualified healthcare professional who can provide personalized guidance based on your individual medical history.